A comparative study of neuroendocrine carcinoma and carcinoid tumor with special reference to expression of HLA-DR antigen and PCNA

Zentralbl Pathol. 1993 Jun;139(2):171-5.

Abstract

Both carcinoid tumor (carcinoid) and neuroendocrine carcinoma (NEC) are composed of neuroendocrine cells which are positive for chromogranin. The former is a low grade malignancy but NEC is a highly aggressive malignancy. We compared histological differences of those tumors using antibodies to major histocompatibility complex (MHC) class II antigens HLA-DR, proliferating cell nuclear antigen (PCNA), Leu7 (CD57), CEA and P53. Most characteristic differences between those tumors were in the expression of HLA-DR and PCNA. HLA-DR positive capillary endothelial cells were abundant in carcinoid as well as in non-tumorous endocrine organs but sparse in NEC. On the contrary, cells positive for PCNA were 92% in NEC, but 27% in carcinoid. We concluded that carcinoid imitates an endocrine organ in both morphology and function, but NEC deviates far from it.

Publication types

  • Comparative Study

MeSH terms

  • Antigens, CD / analysis
  • Antigens, Differentiation, T-Lymphocyte / analysis
  • Antigens, Neoplasm / analysis
  • Biomarkers, Tumor / analysis*
  • CD57 Antigens
  • Carcinoembryonic Antigen / analysis
  • Carcinoid Tumor / pathology*
  • Carcinoid Tumor / surgery
  • Carcinoma / pathology*
  • Carcinoma / surgery
  • Female
  • Gallbladder Neoplasms / pathology
  • HLA-DR Antigens / analysis*
  • HLA-DR Antigens / biosynthesis
  • Humans
  • Liver Neoplasms / pathology
  • Lung Neoplasms / pathology
  • Male
  • Neoplasm Metastasis
  • Nuclear Proteins / analysis*
  • Nuclear Proteins / biosynthesis
  • Proliferating Cell Nuclear Antigen
  • Stomach Neoplasms / pathology
  • Tumor Suppressor Protein p53 / analysis

Substances

  • Antigens, CD
  • Antigens, Differentiation, T-Lymphocyte
  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • CD57 Antigens
  • Carcinoembryonic Antigen
  • HLA-DR Antigens
  • Nuclear Proteins
  • Proliferating Cell Nuclear Antigen
  • Tumor Suppressor Protein p53